drug
Kovaltry
Marketedupdated 3mo agoby Bayer HealthCare Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Trials studying Kovaltry
- —Drug Use Investigation of Kovaltry in Hemophilia A Patients
- phase3A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- phase4A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
- phase3BAY81-8973 Pediatric Safety and Efficacy Trial
- —Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 51m ago
Found something off?
comments(0)
5-min edit window · permanent after that